Neena Brizmohun
Her areas of expertise include the cutting-edge early market access schemes that are being trialed around the world for taking drugs and medical devices to market faster. She is also interested in initiatives for harmonizing regulations at the global level as well as issues affecting clinical trials, manufacturing and post-market safety monitoring. She explores the challenges and opportunities that these issues introduce for both industry and the regulators and is on a constant look out for what might be coming next.
A scientist by training, Neena started her journalistic career at Informa in 1997. She has been the deputy editor of Scrip Regulatory Affairs since 2007. Prior to that, she worked as the science editor for Clinica Medtech Intelligence. Before becoming a journalist she worked as a biomedical scientist at St Thomas' Hospital in London for 10 years.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Neena Brizmohun
NICE Head Sir Andrew Dillon To Stand Down
Sir Andrew Dillon is leaving his role as CEO of England’s health technology assessment body after 20 years.
Sir Andrew Dillon Standing Down As Head Of England’s NICE After 20 Years
Sir Andrew Dillon is stepping down from what has been described as one of the most challenging and potentially controversial roles in British public life.
Sir Andrew Dillon Standing Down As Head Of England’s NICE After 20 Years
Sir Andrew Dillon is stepping down from what has been described as one of the most challenging and potentially controversial roles in British public life.
EU To Join Countries Covered By India’s Clinical Investigation Waiver Rule
Indian regulators intend to waive their clinical investigation requirements for certain medical devices that are already approved in the EU.
Hong Kong Poised To Speed Up Device Approvals
The Medical Device Control Office is to launch a trial program for expediting the approval of certain classes of medical devices.
Raine To Lead UK MHRA Ahead Of Permanent Head Announcement
June Raine has agreed to lead the Medicines and Healthcare products Regulatory Agency temporarily after the agency’s incumbent chief executive steps down in September.